🇺🇸 Amoxycillin/clavulanic acid in United States
34 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 34
Most-reported reactions
- Asthenia — 4 reports (11.76%)
- Pancytopenia — 4 reports (11.76%)
- Pruritus — 4 reports (11.76%)
- Pyrexia — 4 reports (11.76%)
- Acute Kidney Injury — 3 reports (8.82%)
- Dyspnoea — 3 reports (8.82%)
- Hypotension — 3 reports (8.82%)
- Jaundice Cholestatic — 3 reports (8.82%)
- Rash — 3 reports (8.82%)
- Urticaria — 3 reports (8.82%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Amoxycillin/clavulanic acid approved in United States?
Amoxycillin/clavulanic acid does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Amoxycillin/clavulanic acid in United States?
TASK Applied Science is the originator. The local marketing authorisation holder may differ — check the official source linked above.